icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 24th Conference of the Asian Pacific
Association for the Study of the Liver
12-15 March, 2014
Brisbane, Australia
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir Plus Ribavirin, an Interferon-Free Regimen, in the Treatment of Egyptian Patients With Chronic Genotype 4 HCV Infection
 
 
  Reported by Jules Levin
APASL 2015, March 12-15, Istanbul
 
Gamal Shiha1, Gamal Esmat2, Mohamed Hassany3, Rabab Fouad2, Waleed Samir1, Radi Hammad3, Marwa Khairy2, Reham Soliman1, Benedetta Massetto4, Steven J. Knox4, Kathryn Kersey4, Deyuan Jiang4, Brian Doehle4, Diana M. Brainard4, John G. McHutchison4, Wahid Doss3
1Egyptian Liver Research Institute and Hospital (ELRIAH) and Mansoura University, Mansoura, Egypt; 2Cairo University, Cairo, Egypt; 3National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; 4Gilead Sciences, Inc., Foster City, CA, USA

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif